To our knowledge, this work was the first to carry out an integrated analysis of germline and somatic variants for the BRCA1, BRCA2, and TP53 genes in a Brazilian cohort of epithelial ovarian cancer patients, and to evaluate possible associations between tumor mutational profile and survival outcomes in the Brazilian population. The gene discussed is TP53; the disease is ovarian carcinoma.